Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL

Clinical trial condition

Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL

Explore clinical trials studying Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL trial results

Completed

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

NCT03701295

Conditions: Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details